Analysts think DHR stock price could increase by 32%
Apr 01, 2025, 11:25 AM
-2.78%
What does DHR do
Danaher, headquartered in Washington, D.C., employs 61,000 people and operates in Biotechnology, Life Sciences, and Diagnostics, offering products and services for medical and industrial applications.
26 analysts think DHR stock price will increase by 31.85%. The current median analyst target is $270.30 compared to a current stock price of $205.00. The lowest analysts target is $242.40 and the highest analyst target is $325.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
